CoChat

Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial

Open access
Ehrhardt, Stephan, Guo, Nan, Hinz, Rebecca, Schoppen, Stefanie, May, Jürgen, Reiser, Markus, Schroeder, Maximilian Philipp, Schmiedel, Stefan, Keuchel, Martin, Reisinger, Emil C., Langeheinecke, Andreas, de Weerth, Andreas, Schuchmann, Marcus, Schaberg, Tom, Ligges, Sandra, Eveslage, Maria, Hagen, Ralf M., Burchard, Gerd D., Lohse, Ansgar W., for the SacBo Study Group, Ruf, Bernhard, Porschen, Rainer, Trenn, Guido, Butterfaß-Bahloul, Trude, Wuerthwein, Gudrun, Oeder, Frank, Runge, Andreas, Klauss, Esther, Hansen-Rosenblatt, Nina, Werner, Tobias, Schulze, Kornelius, Kreuels, Benno, Schäfer, Guido, Hübener, Peter, Hennigs, Annette, Beisel, Claudia, Fischer-Brügge, Dorothee, Zimmermann-Fraedrich, Katharina, Röder, Claudia, Grigo, Nadine, Riecke, Armin, Schreckenbauer, Helmut, Hemmer, Christoph, Klammt, Sebastian, Geerdes-Fenge, Hilte, Frimmel, Silvius, Kittner, Jens M., Rey, Johannes W., Schattenberg, Joern M., Thieringer, Florian, Schmits, Rudolf, Grandt, Daniel, Büch, Philipp Martin, Klebert, Alexander, Mittag, Marc Andreas, Lehnen, Sybille, Tiefengraber, Daniel, Radecke, Klaus, Hering, Iris, Zeller, Wolfgang, Rundt, Lisa, Brandt, Lars, Baltes, Peter, Dajani, Dani, Kurniawan, Niehls, Pflüger, Carola, Behjat, Nassim, Engel, Ulrike, Unger, Martina · 2016 · Open Forum Infectious Diseases
Cited by 66

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background. Antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD) are common complications of antibiotic use. Data on the efficacy of probiotics to prevent AAD and CDAD are unclear. We aimed to evaluate the efficacy of Saccharomyces boulardii to prevent AAD and CDAD in hospitalized adult patients. Methods. We conducted a multicenter, phase III, double-masked, randomized, placebo-controlled trial in hospitalized patients who received systemic antibiotic treatment in 15 hospitals in Germany between July 2010 and October 2012. Participants received Perenterol forte 250 mg capsules or matching placebo twice per day within 24 hours of initiating antibiotic treatment, continued treatment for 7 days after antibiotic discontinuation, and were then observed for 6 weeks. Results. Two thousand four hundred forty-four patients were screened. The trial was stopped early for futility after inclusion of 477 participants. Two hundred forty-six patients aged 60.1 ± 16.5 years and 231 patients aged 56.5 ± 17.8 were randomized to the S boulardii group and the placebo group, respectively, with 21 and 19 AADs in the respective groups (P = .87). The hazard ratio of AAD in the S boulardii group compared with the placebo group was 1.02 (95% confidence interval, .55–1.90; P = .94). Clostridium difficile-associated diarrhea occurred in 0.8% of participants (4 of 477). Nine serious adverse events were recorded in the S boulardii group, and 3 serious adverse events were recorded in the placebo group. None were related to study participation. Conclusions. We found no evidence for an effect of S boulardii in preventing AAD or CDAD in a population of hospitalized patients without particular risk factors apart from systemic antibiotic treatment. ClinicalTrials.gov Identifier. NCT01143272.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ofid/ofw011

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 66

Metadata

Authors
Ehrhardt, S., Guo, N., Hinz, R., Schoppen, S., May, J., Reiser, M., Schroeder, M. P., Schmiedel, S., Keuchel, M., Reisinger, E. C., Langeheinecke, A., de Weerth, A., Schuchmann, M., Schaberg, T., Ligges, S., Eveslage, M., Hagen, R. M., Burchard, G. D., Lohse, A. W., for the SacBo Study Group, Ruf, B., Porschen, R., Trenn, G., Butterfaß-Bahloul, T., Wuerthwein, G., Oeder, F., Runge, A., Klauss, E., Hansen-Rosenblatt, N., Werner, T., Schulze, K., Kreuels, B., Schäfer, G., Hübener, P., Hennigs, A., Beisel, C., Fischer-Brügge, D., Zimmermann-Fraedrich, K., Röder, C., Grigo, N., Riecke, A., Schreckenbauer, H., Hemmer, C., Klammt, S., Geerdes-Fenge, H., Frimmel, S., Kittner, J. M., Rey, J. W., Schattenberg, J. M., Thieringer, F., Schmits, R., Grandt, D., Büch, P. M., Klebert, A., Mittag, M. A., Lehnen, S., Tiefengraber, D., Radecke, K., Hering, I., Zeller, W., Rundt, L., Brandt, L., Baltes, P., Dajani, D., Kurniawan, N., Pflüger, C., Behjat, N., Engel, U., & Unger, M.
Venue
Open Forum Infectious Diseases
Published
2016-01-01
Volume
3
Issue
1
Pages
ofw011-ofw011
ISSN
2328-8957 (ISSN-L)
OpenAlex
W2296893419
Cited by
66
References
11
FWCI
11.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.